Dr. Timothy Rogers -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Timothy Rogers, a General Surgery physician based in City, VA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Timothy Rogers has received $4,580.75 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Timothy Rogers
- Medical Specialty: General Surgery
- Practice Location: City, VA, Virginia
- NPI Number: 1796336428
- Transparency Score: 50/100
- Payment Records Span: 2024-06-25 to 2024-06-25
Payment Summary
Dr. Timothy Rogers has received a total of $4,580.75 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $4,580.75 per transaction.
- Total Payments Received: $4,580.75
- Number of Transactions: 1
- Average Payment: $4,580.75
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in General Surgery. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Timothy Rogers's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Consulting Fees | $4,580.75 | Advisory board participation, clinical consulting, and expert opinion services |
The largest payment category for Dr. Timothy Rogers is Consulting Fees, accounting for 100% ($4,580.75) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Timothy Rogers. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Johnson & Johnson | $4,580.75 | 1 |
Dr. Timothy Rogers has a financial relationship with Johnson & Johnson, receiving $4,580.75 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Timothy Rogers. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Ibrance -- Referenced in payment records from pharmaceutical companies to Dr. Timothy Rogers
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Timothy Rogers's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Timothy Rogers, a General Surgeon in City, VA, has a pharmaceutical payment profile characterized by a single, recent transaction. With a total of $4,580.75 from pharmaceutical companies, this amount is notably low when compared to the average for General Surgeons. The average total payments for General Surgeons can range significantly, often reaching tens of thousands of dollars annually, with many physicians receiving payments across multiple companies and transaction types. Dr. Rogers' profile, in contrast, shows a singular payment from Johnson & Johnson for consulting services on June 25, 2024. This suggests a focused engagement rather than a broad or ongoing relationship with the pharmaceutical industry. The payment type is exclusively consulting, which is a common form of engagement where physicians share their expertise on product development, clinical trials, or market insights. While any payment from pharmaceutical companies can raise questions, the limited volume and singular nature of these payments for Dr. Rogers do not, on their own, indicate a pattern of routine professional activity that would typically involve numerous interactions. Instead, this appears to be a specific, isolated instance of professional service. For patients, understanding these payments is crucial. While consulting can provide valuable insights for drug development, it's important for patients to recognize that such relationships exist. The key is transparency and whether these relationships influence clinical decisions. In Dr. Rogers' case, the limited scope of payments suggests that his practice is unlikely to be heavily influenced by pharmaceutical industry compensation. Patients should always feel empowered to discuss any concerns about their doctor's relationships with pharmaceutical companies and understand that these payments, especially when infrequent and for specific services, do not automatically equate to compromised patient care. However, maintaining awareness and asking clarifying questions remains a patient's right and a vital part of informed healthcare.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Timothy Rogers is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When considering your doctor's relationship with pharmaceutical companies, it's helpful to understand the context. Payments can range from small meals to significant research grants or consulting fees. While some relationships are normal and can foster innovation, it's wise to be informed. At your next appointment, you might consider asking: 'Are you involved in any consulting or research with pharmaceutical companies?' or 'How do you stay updated on new treatments?' Look for transparency; doctors who are open about their relationships and can articulate how they maintain objectivity are generally a good sign. Red flags might include a doctor who exclusively prescribes medications from a company they receive substantial payments from, or who seems overly dismissive of alternative treatments. It's important to remember that most doctors prioritize patient well-being. However, being aware of potential influences allows you to have more informed conversations about your care. If you have concerns about your doctor's prescribing patterns, discuss them directly, and consider seeking a second opinion if you remain uneasy.
Peer Comparison: How Dr. Timothy Rogers Compares to Other General Surgery Physicians
Dr. Rogers' total pharmaceutical payments of $4,580.75 are significantly lower than the average for General Surgeons. While averages can vary widely based on practice type and academic involvement, many General Surgeons receive payments totaling tens of thousands of dollars annually, often spread across multiple companies and payment types. Dr. Rogers' profile, with a single payment, places him well below the typical range for his specialty, suggesting minimal financial ties to the pharmaceutical industry.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Timothy Rogers in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Johnson & Johnson | $4,580.75 | consulting | Ibrance | 2024-06-25 | Not Assessed |
Frequently Asked Questions About Dr. Timothy Rogers's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Timothy Rogers taking too much pharma money?
Dr. Rogers has received a total of $4,580.75 from pharmaceutical companies, stemming from a single consulting payment. This amount is considerably lower than the average for General Surgeons, who often receive much larger sums spread across multiple interactions. Given the limited volume and singular nature of this payment, it does not suggest an excessive reliance on pharmaceutical industry funding.
What pharma companies pay Dr. Timothy Rogers?
Dr. Timothy Rogers received one payment totaling $4,580.75 from Johnson & Johnson.
Should I switch doctors because of pharma payments?
Switching doctors solely based on pharmaceutical payments is usually not necessary unless you observe a clear pattern of bias or lack of transparency that erodes your trust. Dr. Rogers' payment profile is minimal. Focus on your doctor's communication, treatment recommendations, and your overall comfort level with their care. If you have specific concerns about their prescribing habits or relationships, discuss them openly.
What kinds of payments does this doctor receive?
Dr. Rogers received a single payment of $4,580.75 for consulting services from Johnson & Johnson on June 25, 2024. This is the only recorded payment in his profile, indicating a specific engagement for his expertise.
How do these payments compare to other General Surgery?
Dr. Rogers' total payments of $4,580.75 are substantially lower than the typical range for General Surgeons. Many physicians in this specialty receive significantly higher amounts, often in the tens of thousands of dollars annually, reflecting more extensive engagement with pharmaceutical companies.
Do pharma payments affect prescribing quality?
Research indicates that even small payments can subtly influence prescribing habits. However, the impact varies greatly depending on the amount, type of payment, and the individual physician. For Dr. Rogers, with a single, relatively small consulting fee, the direct impact on his overall prescribing quality is likely minimal, but awareness is always prudent.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Visit the official CMS Open Payments website, search for 'Timothy Rogers' and his NPI '1796336428', and review the detailed records of payments made to him by pharmaceutical and medical device companies.
Understanding This Doctor Payment Report
This transparency report for Dr. Timothy Rogers is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. General Surgery physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Timothy Rogers's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Timothy Rogers and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- General Surgery Specialty Payment Data -- See payment patterns for all general surgery physicians
- Virginia Physician Payments -- Browse pharmaceutical payments to physicians in Virginia
- General Surgery Physicians in Virginia -- Compare Dr. Timothy Rogers to peers in the same state and specialty
- Johnson & Johnson Payment Profile -- View all payments made by Dr. Timothy Rogers's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Timothy Rogers's NPI (1796336428) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.